Cytokinetics, Incorporated · NASDAQ:CYTK

Blum Robert I sold 7,500 Cytokinetics, Incorporated shares (Form 4)

Traded Jun 15, 2026 · Filed Jun 15, 2026

On Jun 15, 2026, Blum Robert I (Director, President & CEO) sold 7,500 Cytokinetics, Incorporated shares at US$70.46 for US$528K under a trading plan, leaving 385,330 shares. Filed Jun 15, 2026 (Form 4).

Sold
7,500 shares
Price
US$70.46
Value
US$528K
Holding after
385,330 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 15, 2026Common StockSale7,500US$70.46385,330Direct

Source

View original at SEC

Related